Stock Updates

How has Eli Lilly and Company:(NYSE:LLY) performed recently?

Eli Lilly and Company (NYSE: LLY) is a large market cap stock with a market cap of 89654.41. It is in the Drug Manufacturers – Major industry and sector Healthcare, with a current P/E of 35.24, a forward P/E of 20.03 and EPS of 2.32. At a stock price of 81.75 (0.79%) it has a dividend yield of 2.50%.

EPS growth for the last five years have been -13.20%, more recently this last year it has grown by 1.60%. The next year growth is going to be about 13.80% and more long-term 13.06% after five years. EPS growth quarter over quarter is 25.10%. Sales growth for the past five years have been -2.90% and sales growth quarter over quarter is 8.60%.

For performance, Eli Lilly and Company the past week has seen a gain of 1.29%. For the last month performance for Eli Lilly and Company is 4.13%. While the last quarter is 3.72% and half year, 11.03%. Finally for the year, performance is -0.29%.

The 52-week high for Eli Lilly and Company, is at -5.40%, and for the 52-week low it comes to a value of 22.01%. The 20-day simple moving average is 2.24% and 6.57% for the 200-day simple moving average.

Volatility for the week is at 1.21%, and for the month it is 1.33%. Eli Lilly and Company, has a target price of 97.8.

In terms of debt, long term debt/equity is 0.59, and for total debt/equity Eli Lilly and Company has 0.64. The gross margin is 73.70%, while operating margin is 14.60%, the profit margin is 12.00%. The current ratio is 1.5 and the quick ratio is 1.1.

Insider ownership is at 11.40%, with instituitional ownership at 77.10%. Eli Lilly and Company has a payout ratio of 91.20%. With the total shares outstanding coming to 1096.69. The shares float is 1096.69, with the float short at 0.59%, with short ratio coming to 1.89.

In terms of returns, the return on assets see Eli Lilly and Company, get 6.90%, with its returns on investment at 9.50%. Return on equity is 16.60%. So will the investors see the target price of 97.8, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Mark Hines

Leave a Comment